Previous 10 | Next 10 |
2023-07-16 10:24:01 ET Summary XPH’s consistent low yield and poor price growth (mostly negative) over both short-run as well as over long-run should be disheartening for investors. Expiration of a large number of patents within 2030, and narrow revenue stream expected from...
2023-07-11 21:25:00 ET Summary Health care’s innovation-driven growth and inherent resilience makes it a natural fit for dividend growth investors, according to Franklin Equity Group. Technology in health care has historically driven a broad range of innovation, from the do...
2023-07-09 12:00:00 ET Despite a disappointing start to 2023, the healthcare sector has several promising industries waiting to outperform this year, Goldman Sachs said in a recent report after the bank concluded its annual healthcare conference in Dana Point, California, last month. Th...
2023-07-08 04:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-06-21 07:20:12 ET SPDR S&P Pharmaceuticals ETF ( XPH ) - $0.1235 . 30-Day SEC Yield of 1.14% as of Jun. 15. Payable Jun 23; for shareholders of record Jun 21; ex-div Jun 20. For further details see: SPDR S&P Pharmaceuticals ETF declares quarterly dis...
2023-06-09 07:36:00 ET Summary Healthcare companies are beginning to explore how artificial intelligence might unlock efficiencies for patients and medical systems. Companies that put cash to work by investing in innovation are signaling efforts to secure consistent long-term prof...
2023-06-09 02:00:00 ET Summary Recent clinical trial success for the second significant, disease-modifying drug to treat Alzheimer’s is a critical milestone and a positive sign for the future of neuroscience. Technological advancements, particularly artificial intelligence ...
2023-05-29 10:57:56 ET Summary iShares Select Dividend ETF offers high quarterly income checks, steady income growth, and broad diversification. Weak 3-month price change could be opening a smart buy entry for new capital. DVY could be a core position in an income-oriented por...
2023-05-29 09:00:00 ET Summary PFE's historical stock performance remains mediocre compared to its pharmaceutical peers, even after adjusting for dividends. Combined with its decelerating COVID-19 portfolio and $22B worth of annualized patent cliff from 2025 onwards, we are not su...
2023-05-17 00:15:00 ET Summary One of the most promising applications of AI in drug discovery is in the identification of new drug targets (AI can be used to discover new drugs). The ability to analyze large amounts of molecular and genomic data quickly and efficiently is somethin...
News, Short Squeeze, Breakout and More Instantly...
SPDR S&P Pharmaceuticals Company Name:
XPH Stock Symbol:
NYSE Market:
2024-07-19 12:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Transaction highlights: To acquire CommScope’s Outdoor Wireless Networks and Distributed Antenna Systems businesses for $2.1 billion in cash Adds advanced antenna and associated interconnect products, technologies and capabilities Complements Amphenol’s existing prod...
Amphenol Corporation (NYSE: APH) today announced it had completed the acquisition of the Carlisle Interconnect Technologies (CIT) business from Carlisle Companies Incorporated (NYSE: CSL). “The acquisition of CIT enhances Amphenol’s product offerings for highly engineered harsh ...